Spots Global Cancer Trial Database for mat2a inhibitor
Every month we try and update this database with for mat2a inhibitor cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Study of AG-270 in Participants With Advanced Solid Tumors or Lymphoma With MTAP Loss | NCT03435250 | Advanced Solid ... Lymphoma | AG-270 AG-270 AG-270 docetaxel nab-paclitaxel gemcitabine | 18 Years - | Servier | |
Study of IDE397 in Participants With Solid Tumors Harboring MTAP Deletion | NCT04794699 | Solid Tumor | IDE397 Docetaxel Paclitaxel Sacituzumab gov... | 18 Years - | IDEAYA Biosciences | |
Study of AG-270 in Participants With Advanced Solid Tumors or Lymphoma With MTAP Loss | NCT03435250 | Advanced Solid ... Lymphoma | AG-270 AG-270 AG-270 docetaxel nab-paclitaxel gemcitabine | 18 Years - | Servier | |
S095035 in Adult Participants With Advanced or Metastatic Solid Tumors With Deletion of the Methylthioadenosine Phosphorylase (MTAP) Gene | NCT06188702 | MTAP-deleted So... | S095035 | 18 Years - | Servier |